SEI Investments’s Pacific Biosciences PACB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-28,004
| Closed | -$51.2K | – | 2818 |
|
2024
Q4 | $51.2K | Sell |
28,004
-91,853
| -77% | -$168K | ﹤0.01% | 2664 |
|
2024
Q3 | $204K | Sell |
119,857
-523,579
| -81% | -$890K | ﹤0.01% | 2470 |
|
2024
Q2 | $882K | Sell |
643,436
-914,278
| -59% | -$1.25M | ﹤0.01% | 1954 |
|
2024
Q1 | $5.84M | Sell |
1,557,714
-282,359
| -15% | -$1.06M | 0.01% | 1136 |
|
2023
Q4 | $18.1M | Buy |
1,840,073
+642,400
| +54% | +$6.3M | 0.03% | 613 |
|
2023
Q3 | $10M | Sell |
1,197,673
-250,019
| -17% | -$2.09M | 0.02% | 859 |
|
2023
Q2 | $19.3M | Sell |
1,447,692
-708,474
| -33% | -$9.42M | 0.03% | 577 |
|
2023
Q1 | $25M | Sell |
2,156,166
-495,421
| -19% | -$5.74M | 0.05% | 444 |
|
2022
Q4 | $21.7M | Sell |
2,651,587
-841,675
| -24% | -$6.88M | 0.05% | 428 |
|
2022
Q3 | $20.3M | Sell |
3,493,262
-356,287
| -9% | -$2.07M | 0.05% | 457 |
|
2022
Q2 | $17M | Sell |
3,849,549
-86,738
| -2% | -$383K | 0.04% | 524 |
|
2022
Q1 | $35.8M | Buy |
3,936,287
+1,261,333
| +47% | +$11.5M | 0.07% | 295 |
|
2021
Q4 | $54.7M | Buy |
2,674,954
+146,263
| +6% | +$2.99M | 0.1% | 207 |
|
2021
Q3 | $64.6M | Sell |
2,528,691
-20,534
| -0.8% | -$525K | 0.14% | 153 |
|
2021
Q2 | $89.1M | Buy |
2,549,225
+436,096
| +21% | +$15.3M | 0.2% | 91 |
|
2021
Q1 | $70.4M | Sell |
2,113,129
-55,907
| -3% | -$1.86M | 0.18% | 100 |
|
2020
Q4 | $56.3M | Buy |
+2,169,036
| New | +$56.3M | 0.15% | 127 |
|